Another in a series of hearings with pharma CEOs takes place today.
Medicare
Posted inHealth and Social Policy
Casualties of a Failed Health Care System
Why even an elite Boston hospital can feel like a makeshift infirmary in a war zone
Posted inHealth and Social Policy
The Great Medicare Advantage Marketing Scam
How for-profit health insurers convince seniors to enroll in private Medicare plans
Posted inMoney, Politics, and Power
Democrats Could Score Big by Blocking This Revolver
Demetrios Kouzoukas’s nomination battle offers the perfect opportunity for Democrats to prove themselves to voters.
Posted inHealth and Social Policy
Euthanize This (Merger)
The merger of Cigna and Humana, America’s fifth- and sixth-largest for-profit health insurers, would create a monster middleman to ‘compete’ with the undisputed giant, UnitedHealth.
Posted inHealth and Social Policy
The Medicare Advantage Trap
In 46 states, once you choose Medicare Advantage at 65, you can almost never leave.
Posted inHealth and Social Policy
We May Not Negotiate Prices for Ten Drugs After All
Rules that exempt drugs from Medicare negotiation if there’s ‘meaningful’ generic competition could whittle down the effect of the program.
Posted inHealth and Social Policy
Medicare Price Negotiation: Ten Drugs That Made the List, and Ten That Should Have
Advocates were thrilled that Medicare will negotiate the price of several insulins. But other high-profit drugs are protected by the new program’s rules.
Posted inHealth and Social Policy
Pricing a Lifesaving Drug
Will Medicare use its ample leverage to make Wegovy affordable?
Posted inMoney, Politics, and Power
Who’s Running Big Pharma’s Last Stand Against Slightly Fairer Drug Pricing
One year after IRA passage, bad actors try to thwart drug price negotiation, and Biden’s efforts to defend it fall short.